Seeing Is Believing
Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (25%), 1 are a SELL (25%), 2 are a BUY (50%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 25% that have a potential upside of 2.92% achieved within 144 days.
Florent Cespedes’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$928
$104.38 (12.67%)
$1030
25 days ago
(14-Apr-2025)
16/18 (88.89%)
$173.65 (23.02%)
539
Buy
$1124
$300.38 (36.47%)
$1158
1 months ago
(09-Apr-2025)
29/34 (85.29%)
$370.29 (49.13%)
176
Buy
$1100
$276.38 (33.56%)
$970
2 months 4 days ago
(05-Mar-2025)
13/16 (81.25%)
$170.28 (18.32%)
66
Buy
$1038
$214.38 (26.03%)
$1033
3 months 6 days ago
(03-Feb-2025)
1/4 (25%)
$228.96 (28.30%)
55
Buy
$1190
$366.38 (44.48%)
$1250
3 months 11 days ago
(28-Jan-2025)
0/3 (0%)
$386.39 (48.08%)
What Year was the first public recommendation made by Florent Cespedes?